Alpha Teknova, Inc. (TKNO)Healthcare | Drug Manufacturers - Specialty & Generic | Hollister, United States | NasdaqGM
5.41 USD
+0.05
(0.933%)
⇧
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 4 a.m. EDT
Alpha Teknova presents a stark dichotomy between a fundamentally broken business and a speculative trading opportunity. The long-term outlook is severely compromised; the company has endured four consecutive years of massive value destruction, dropping nearly 80% from its peak, while burning through cash with negative free cash flow and a negative operating margin. Despite a recent price rebound, the underlying fundamentals—negative earnings, deteriorating returns on equity, and a lack of sustainable profitability—justify a 'avoid' rating for any investor seeking capital preservation or steady growth. However, the short-term picture tells a different story driven purely by sentiment and technicals. The stock has rallied significantly from its lows, and the options market reflects a 'long gamma' environment where traders are betting on volatility expansion rather than immediate direction. The heavy put wall at $2.50 acts as a psychological floor, while the $10 call activity hints at hopes for a catalyst. For a trader, this is a volatile, high-risk setup where the price could bounce off support or continue its grind lower; for a fundamental investor, the business quality is currently non-existent. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.298141 |
| MSTL | 0.304022 |
| AutoTheta | 0.308920 |
| AutoARIMA | 0.310346 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 12.31 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.187 |
| Excess Kurtosis | -1.31 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 42.861 |
| Revenue per Share | 0.781 |
| Market Cap | 290,051,872 |
| Forward P/E | -22.08 |
| Beta | 0.63 |
| Profit Margins | -41.07% |
| Website | https://www.teknova.com |
As of July 11, 2026, 4 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume at the $2.50 strike, creating a significant barrier at the 52-week low. Conversely, there is notable call interest at the $10.00 strike for the December expiration, suggesting a speculative bet on a potential recovery to near-recovery highs, though immediate-term call activity remains thin.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.19376397 |
| Address1 | 2,451 Bert Dr. |
| All Time High | 30.89 |
| All Time Low | 1.155 |
| Ask | 6.8 |
| Ask Size | 2 |
| Audit Risk | 4 |
| Average Daily Volume10 Day | 182,730 |
| Average Daily Volume3 Month | 168,124 |
| Average Volume | 168,124 |
| Average Volume10Days | 182,730 |
| Beta | 0.627 |
| Bid | 3.9 |
| Bid Size | 2 |
| Board Risk | 10 |
| Book Value | 1.211 |
| City | Hollister |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.41 |
| Current Ratio | 4.593 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 5.48 |
| Day Low | 5.25 |
| Debt To Equity | 42.861 |
| Display Name | Alpha Teknova |
| Earnings Call Timestamp End | 1,778,104,800 |
| Earnings Call Timestamp Start | 1,778,104,800 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,785,960,000 |
| Earnings Timestamp Start | 1,785,960,000 |
| Ebitda | -9,472,000 |
| Ebitda Margins | -0.22659001 |
| Enterprise To Ebitda | -31.682 |
| Enterprise To Revenue | 7.179 |
| Enterprise Value | 300,094,880 |
| Eps Current Year | -0.325 |
| Eps Forward | -0.245 |
| Eps Trailing Twelve Months | -0.31 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.5584 |
| Fifty Day Average Change | 0.8515997 |
| Fifty Day Average Change Percent | 0.18681987 |
| Fifty Two Week Change Percent | 19.376396 |
| Fifty Two Week High | 6.68 |
| Fifty Two Week High Change | -1.27 |
| Fifty Two Week High Change Percent | -0.19011976 |
| Fifty Two Week Low | 1.91 |
| Fifty Two Week Low Change | 3.5 |
| Fifty Two Week Low Change Percent | 1.8324608 |
| Fifty Two Week Range | 1.91 - 6.68 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,624,627,800,000 |
| Float Shares | 10,879,895 |
| Forward Eps | -0.245 |
| Forward P E | -22.08163 |
| Free Cashflow | -2,387,875 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 158 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.34013 |
| Gross Profits | 14,218,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.093219995 |
| Held Percent Institutions | 0.84726995 |
| Implied Shares Outstanding | 53,614,028 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,021-06-25 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California. |
| Long Name | Alpha Teknova, Inc. |
| Market | us_market |
| Market Cap | 290,051,872 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_116531601 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -17,169,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 290,051,891 |
| Number Of Analyst Opinions | 3 |
| Open | 5.3 |
| Operating Cashflow | -7,902,000 |
| Operating Margins | -0.38801 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 831 637 1100 |
| Previous Close | 5.36 |
| Price Eps Current Year | -16.646154 |
| Price Hint | 2 |
| Price To Book | 4.4673824 |
| Price To Sales Trailing12 Months | 6.938708 |
| Profit Margins | -0.41072 |
| Quick Ratio | 3.401 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0499997 |
| Regular Market Change Percent | 0.93283 |
| Regular Market Day High | 5.48 |
| Regular Market Day Low | 5.25 |
| Regular Market Day Range | 5.25 - 5.48 |
| Regular Market Open | 5.3 |
| Regular Market Previous Close | 5.36 |
| Regular Market Price | 5.41 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 207,542 |
| Return On Assets | -0.092930004 |
| Return On Equity | -0.23923999 |
| Revenue Growth | 0.131 |
| Revenue Per Share | 0.781 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 53,614,028 |
| Shares Percent Shares Out | 0.0233 |
| Shares Short | 1,251,824 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,109,886 |
| Short Name | Alpha Teknova, Inc. |
| Short Percent Of Float | 0.114700004 |
| Short Ratio | 5.02 |
| Source Interval | 15 |
| State | CA |
| Symbol | TKNO |
| Target High Price | 12.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 9.0 |
| Target Median Price | 8.0 |
| Total Cash | 17,784,000 |
| Total Cash Per Share | 0.332 |
| Total Debt | 27,827,000 |
| Total Revenue | 41,802,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.31 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.0125 |
| Two Hundred Day Average Change | 1.3975 |
| Two Hundred Day Average Change Percent | 0.34828663 |
| Type Disp | Equity |
| Volume | 207,542 |
| Website | https://www.teknova.com |
| Zip | 95,023 |